Lisa Kinget
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Local control of RCC pancreatic metastases is obtained by angiogenesis inhibitors.
Journal: Acta clinica Belgica
Published: September 03, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 26, 2026
Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma.
Journal: Cancer research communications
Published: September 10, 2025
Trial watch: anticancer vaccination with dendritic cells.
Journal: Oncoimmunology
Published: October 14, 2024
Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.
Journal: Nature medicine
Published: July 15, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab.
Journal: Acta oncologica (Stockholm, Sweden)
Published: March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 13, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Journal: Oncoimmunology
Published: June 07, 2023
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
Journal: Oncoimmunology
Published: July 08, 2022
Last Updated: 09/26/2026